Results 291 to 300 of about 212,304 (319)

Pharmaceutical economics & health policy

Clinical Therapeutics, 1999
David A. Sclar
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Economic Evaluation of Pharmaceuticals

PharmacoEconomics, 1992
The increased pressures on health care budgets have emphasised the need to demonstrate the value for money from health technologies. Most major pharmaceutical companies have therefore commissioned cost-benefit or cost-effectiveness analysis of their products. There is an assumed analogy between clinical trains, which are required for product licensing,
openaire   +4 more sources

Pharmaceutical economics & health policy

Clinical Therapeutics, 1998
David A. Sclar
  +5 more sources

Economic Evaluation of Pharmaceuticals

PharmacoEconomics, 1993
In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals. Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products. In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have ...
Michael Drummond, Frans Rutten, Antonio Brenna, Carlos Gouveia Pinto, Bruno Horisberger, Bengt Jönsson, Claude Le Pen, Joan Rovira, Matthias Graf von der Schulenburg, Harri Sintonen, Koen Torfs   +10 more
openaire   +2 more sources

Economic analysis and pharmaceutical policy

Anaesthesia, 1995
Summary Economic evaluation, a comparative analysis of alternative actions in terms of costs and consequences, allows rational decisions to be made concerning the deployment of resources (people, time, equipment, facilities and knowledge).
openaire   +2 more sources

Pharmaceutical Economics [PDF]

Business Economics, 2008
The role economists play in shaping the direction and outcome of business research and policy decisions of a very important part of the healthcare industry—the pharmaceutical industry.Business Economics (2008) 43, 65–68; doi:10.2145 ...
openaire  

Pharmaceutical Economics and Policy

2018
Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this book explores the conflicting priorities and aims of the biopharmaceutical industry. It starts out by describing the supply side of pharmaceuticals in all
Stuart O. Schweitzer, Z. John Lu
openaire   +1 more source

Pharmaceutical Economics And Policy

2006
Abstract The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive ...
openaire   +1 more source

Economic evaluation for pharmaceuticals in Germany

The European Journal of Health Economics, 2007
Springer-Verlag 2007 With the new legislation in Germany, cost-benefit assessment can be used to stipulate maximum reimbursement amounts for pharmaceuticals. According to the law, the Institute for Quality and Efficiency in the Health Care Sector (IQWiG) can be commissioned by the Federal Joint Committee (G-BA) and the Ministry of Health with the ...
openaire   +2 more sources

Economic evaluation and pharmaceutical policy

2005
This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with ...
J.L. Pinto Prades, X. Badía Llach
openaire   +1 more source